0.76 - 0.86
0.53 - 11.72
227.7K / 102.3K (Avg.)
-0.11 | -7.01
Analyze DCF forecasts for the company and compare them with competitors.
388.00K
Revenue has decreased from the previous period.
-43.02%
Revenue growth rate has decreased from the previous period.
-67.93M
EBITDA has decreased from the previous period.
-17508.25%
EBITDA margin has decreased from the previous period.
-68.10M
EBIT has decreased from the previous period.
-17551.03%
EBIT margin has decreased from the previous period.
166.00K
Depreciation has increased from the previous period.
46.37M
No previous data to compare.
11952.06%
No previous data to compare.
261.00K
No previous data to compare.
67.27%
No previous data to compare.
271.00K
No previous data to compare.
69.85%
No previous data to compare.
970.00K
No previous data to compare.
250.00%
No previous data to compare.
-595.00K
Capital expenditure has increased from the previous period.
-153.35%
CapEx percentage has increased from the previous period.
14.73%
WACC has increased from the previous period.
18.72%
Cost of equity is unchanged from the previous period.
4.40%
Cost of debt is unchanged from the previous period.
3.03
Beta is unchanged from the previous period.
10.09M
Diluted shares outstanding is unchanged from the previous period.
38.68M
Total debt is unchanged from the previous period.
100.27M
Total equity is unchanged from the previous period.
138.95M
Total capital is unchanged from the previous period.
27.83%
Debt weighting is unchanged from the previous period.
72.17%
Equity weighting is unchanged from the previous period.
-67.71M
EBIAT has decreased from the previous period.
-67.70M
UFCF has decreased from the previous period.
2.00%
Long-term growth rate is unchanged from the previous period.
-65.41K
Terminal value is unchanged from the previous period.
-2.65M
Enterprise value has increased from the previous period.
-2.56M
Net debt is unchanged from the previous period.
-94.08K
Equity value has increased from the previous period.
-0.01
Equity value per share has increased from the previous period.
Analyze analyst forecasts for the company and compare them with competitors.
4.55B
The estimated revenue has increased from the previous period.
-2.73B
The estimated EBITDA has decreased from the previous period.
-1.32
The estimated EPS has decreased from the previous period.
-21.03M
The estimated net income has decreased from the previous period.
-2.73B
The estimated EBIT has decreased from the previous period.
39980.93B
The estimated SG&A expenses have increased from the previous period.
View analysts' price targets and recommendations, and compare them with competitors.
$1.00
Analysts expect the stock price to increase by 29.03%.
Buy
Positive consensus among analysts.
